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The authors of this paper have advised that [Table 1](#T0001){ref-type="table"} is incorrect. The authors advised that they had listed values for Cmax and Ctrough after a single dose of Brixadi (CAM2038) and not steady state, as it was provided for Sublocade. The new [Table 1](#T0001){ref-type="table"} reflects the Brixadi steady state concentrations for a more direct comparison with Sublocade.Table 1Comparison of Long-Acting Formulations of Buprenorphine FDA-Approved for Treatment of Opioid Use DisorderBrand NameProbuphineSublocadeBrixadi (US) or Buvidal (Europe/Australia)Molecular nameRBP-6000CAM2038PharmaceuticalPreviously Braeburn, currently TitanIndiviorBraeburn Pharmaceuticals/CamurusIndicated populationStable transmucosal buprenorphine dose of 8 mg or less for three months or longerInitiated transmucosal buprenorphine (8--24 mg) for a minimum of 7 days.Initiation of treatment in patients not already receiving buprenorphine or switching from transmucosal buprenorphineRoute of administrationSubcutaneous implantSubcutaenous injectionSubcutaenous injectionDuration of effect6 months1 month1 week or 1 monthDosage320 mg (Four 80 mg implants)100 and 300 mg8, 16, 24 and 32 mg (weekly) or 64, 96 and 128 mg (monthly)Long acting technologyEthylene vinyl acetate (EVA) polymer18% (weight/weight) buprenorphine base in the ATRIGEL Delivery SystemProlonged release FluidCrystal injection depot technologyLocationUpper armAbdomenButtock, thigh, stomach (abdomen) or upper armFDA-approval201620172018 (tentative)Plasma concentrations (ng/mL)C~max~C~max~C~max~3.234.88 (100 mg)Weekly 4.3--6.910.12 (300 mg)Monthly 4.0--11.1C~trough~C~trough~C~trough~0.722.48 (100 mg)Weekly 0.8--2.65.01 (300 mg)Monthly 1.3--2.1Provider burden+++++++Live training programSupervised injectionSupervised injectionProcedural competencyMonthly injectionsWeekly or monthly injectionsSpecial Handling RequirementsRequires implant procedureNeeds RefrigerationNo special requirementsNeed for removal or replacement every 6 monthsInjection only under skin around umbilicus

The correct [Table 1](#T0001){ref-type="table"} is as follows:
